Winston Medical Supply Co., Ltd. (TPEX:6817)
68.30
+0.10 (0.15%)
Apr 20, 2026, 1:13 PM CST
Winston Medical Supply Revenue
In the year 2025, Winston Medical Supply had annual revenue of 700.07M TWD with 0.72% growth. Winston Medical Supply had revenue of 358.83M in the half year ending June 30, 2025, with 5.70% growth.
Revenue
700.07M
Revenue Growth
+0.72%
P/S Ratio
1.79
Revenue / Employee
3.89M
Employees
180
Market Cap
1.26B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 700.07M | 5.00M | 0.72% |
| Dec 31, 2024 | 695.08M | -14.00M | -1.97% |
| Dec 31, 2023 | 709.07M | 102.56M | 16.91% |
| Dec 31, 2022 | 606.52M | 69.99M | 13.05% |
| Dec 31, 2021 | 536.53M | 31.41M | 6.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| TSH Biopharm Corporation | 1.34B |
| Prince Pharmaceutical | 1.06B |
| Excelsior Biopharma | 898.26M |
| Anxo Pharmaceutical | 883.22M |
| DV Biomed | 794.18M |
| GeneFerm Biotechnology | 677.10M |
| Johnson Chemical Pharmaceutical Works | 569.77M |
| Tien Liang BioTech | 511.79M |